Abstract Antibody-drug conjugates (ADCs) are potential therapeutics combining two molecules linked together: an antibody that provides targeting to specific cells, and a warhead drug that can deconjugate from the antibody and kill those cells. The warhead drug by itself would be too nonspecific; the antibody by itself would be insufficiently effective at killing the cells.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile